Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
grade D 131.86 -0.48% -0.64
JNJ closed down 0.48 percent on Wednesday, July 17, 2019, on 1.24 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JNJ trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Earnings Movers Other 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Cup with Handle Other -0.48%
Calm After Storm Range Contraction -0.48%
Lower Bollinger Band Walk Weakness -0.48%

Older signals for JNJ ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Health Pain Infectious Diseases Retail Outlets Infection Pharmacology Healthcare Industry Pain Management Cardiovascular Disease Diagnostic Products Energy Products General Surgery Thrombosis Insulin Delivery Infection Prevention Products Johnson & Johnson
Is JNJ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 148.99
52 Week Low 121.0
Average Volume 7,014,884
200-Day Moving Average 137.3812
50-Day Moving Average 138.3878
20-Day Moving Average 139.637
10-Day Moving Average 137.967
Average True Range 2.3307
ADX 20.56
+DI 15.9473
-DI 41.6094
Chandelier Exit (Long, 3 ATRs ) 137.9879
Chandelier Exit (Short, 3 ATRs ) 138.4021
Upper Bollinger Band 146.4335
Lower Bollinger Band 132.8405
Percent B (%b) -0.07
BandWidth 9.734526
MACD Line -1.2933
MACD Signal Line -0.1251
MACD Histogram -1.1682
Fundamentals Value
Market Cap 353.91 Billion
Num Shares 2.68 Billion
EPS 5.75
Price-to-Earnings (P/E) Ratio 22.93
Price-to-Sales 5.12
Price-to-Book 5.29
PEG Ratio 2.79
Dividend 3.36
Dividend Yield 2.55%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 135.12
Resistance 3 (R3) 135.33 134.45 134.57
Resistance 2 (R2) 134.45 133.62 134.35 134.39
Resistance 1 (R1) 133.16 133.11 132.72 132.95 134.21
Pivot Point 132.28 132.28 132.07 132.18 132.28
Support 1 (S1) 130.99 131.45 130.55 130.78 129.51
Support 2 (S2) 130.11 130.94 130.01 129.33
Support 3 (S3) 128.82 130.11 129.15
Support 4 (S4) 128.61